ClinicalTrials.gg
Sign In

Vestibular Diseases clinical trials

The registry lists 170 studies for Vestibular Diseases across more than 10 countries. 41 are recruiting or about to start. 111 of them are mainly about Vestibular Diseases (how this is decided). Per ClinicalTrials.gov, last updated 2026-11-09. Counting its 2 narrower conditions too, such as Vertigo: 373 studies, 75 open.

Get an email when these change. Save the Vestibular Diseases studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Watch these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your saved searches, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your saved searches. Stop any time.

Status

Completed
86
Status unknown
24
Recruiting
21
Not yet recruiting
14
Withdrawn
9
Terminated
6

Phase

Phase 2
5
Phase 4
2
Phase 1
2
Early Phase 1
1

Where

United States
54
Turkey
15
Belgium
10
Pakistan
10
France
9
United Kingdom
8

Who runs them

Riphah International University (7) · Johns Hopkins University (6) · University of Pittsburgh (5) · Massachusetts Eye and Ear Infirmary (5) · University Hospital, Ghent (4) · Aalborg University Hospital (4) · Eye & ENT Hospital of Fudan University (4) · University of Zurich (3)

What is being tested here

Drugs under test in Vestibular Diseases studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted

DrugOpenPhase 3All
Lamotrigine002
Caffeine001
Prednisone001
Betamethasone001
Prednisolone001
Bupropion001
Betahistine001
4-Aminopyridine001
Atenolol001
Thioctic Acid001

Coming up

0phase 3 studies under way
11studies finish main data collection within a year

Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.

The 10 nearest

Who these studies take

Of the 21 Vestibular Diseases studies recruiting now, 6 (29%) set no upper age limit and 9 (43%) stop at 75 or younger. 6 (29%) take children under 18. 0 (0%) are for women only and 0 (0%) for men only; 7 (33%) take healthy volunteers.

Recruiting studies that take each age, of 21
AgeWomenMen
105 (24%)5 (24%)
189 (43%)9 (43%)
3014 (67%)14 (67%)
4014 (67%)14 (67%)
5014 (67%)14 (67%)
6513 (62%)13 (62%)
7512 (57%)12 (57%)
8511 (52%)11 (52%)

Across all 170 studies, recruiting or not: 46% stop at 75 or younger and 35% at 65; 17% take children; 1% are for women only and 1% for men only; 30% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.

How long Vestibular Diseases studies take

Of 84 interventional studies with no phase under Vestibular Diseases, half reached primary completion within 15 months of starting, counting those still running.

Start to primary completionEvery sponsorIndustryNon-industry
Interventional, no phase15 mo8–34 · 84 studies—16 mo8–37 · 79 studies

Each figure is the month by which half the studies had reached primary completion, with the range in which the middle half did. Studies still running count until their last registry update; studies that stopped early are left out. Phase 1 includes early phase 1; observational means prospective or not stated, as retrospective and cross-sectional studies date a window of data rather than a study. How these figures are worked out

What changed recently

From the registry's own updates since Oct 13, 2026.

Started recruiting2

Studies

Recruiting first, then most recently updated. Showing 50 of 170. Browse all 170 → or search them.